These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

329 related items for PubMed ID: 14681724

  • 21. Transcriptional regulation of the human glycoprotein hormone common alpha subunit gene by cAMP-response-element-binding protein (CREB)-binding protein (CBP)/p300 and p53.
    Zhang X, Grand RJ, McCabe CJ, Franklyn JA, Gallimore PH, Turnell AS.
    Biochem J; 2002 Nov 15; 368(Pt 1):191-201. PubMed ID: 12164786
    [Abstract] [Full Text] [Related]

  • 22. Methods to study p53-repressed promoters.
    Dumont P, Della Pietra A, Murphy ME.
    Methods Mol Biol; 2003 Nov 15; 234():111-20. PubMed ID: 12824528
    [Abstract] [Full Text] [Related]

  • 23. Heat-directed gene targeting of adenoviral vectors to tumor cells.
    Brade AM, Ngo D, Szmitko P, Li PX, Liu FF, Klamut HJ.
    Cancer Gene Ther; 2000 Dec 15; 7(12):1566-74. PubMed ID: 11228535
    [Abstract] [Full Text] [Related]

  • 24. Adenoviral-mediated skeletal muscle transcriptional targeting using chimeric tissue-specific promoters.
    Frauli M, Ribault S, Neuville P, Augé F, Calenda V.
    Med Sci Monit; 2003 Feb 15; 9(2):BR78-84. PubMed ID: 12601283
    [Abstract] [Full Text] [Related]

  • 25. Targeted-simultaneous expression of Gas1 and p53 using a bicistronic adenoviral vector in gliomas.
    Benítez JA, Arregui L, Vergara P, Segovia J.
    Cancer Gene Ther; 2007 Oct 15; 14(10):836-46. PubMed ID: 17599090
    [Abstract] [Full Text] [Related]

  • 26. Development of a novel recombinant adenovirus containing gfp-zeocin fusion expression cassette for conditional replication in p53-deficient human tumor cells.
    Hu B, Joshua MN, Dong C, Qi Y.
    J Virol Methods; 2004 May 15; 117(2):129-36. PubMed ID: 15041209
    [Abstract] [Full Text] [Related]

  • 27. Adenovirus-mediated p53 gene therapy: overview of preclinical studies and potential clinical applications.
    Horowitz J.
    Curr Opin Mol Ther; 1999 Aug 15; 1(4):500-9. PubMed ID: 11713766
    [Abstract] [Full Text] [Related]

  • 28. The BCL6 proto-oncogene suppresses p53 expression in germinal-centre B cells.
    Phan RT, Dalla-Favera R.
    Nature; 2004 Dec 02; 432(7017):635-9. PubMed ID: 15577913
    [Abstract] [Full Text] [Related]

  • 29. Transcriptional repression of the human p53 gene by hepatitis B viral core protein (HBc) in human liver cells.
    Kwon JA, Rho HM.
    Biol Chem; 2003 Feb 02; 384(2):203-12. PubMed ID: 12675512
    [Abstract] [Full Text] [Related]

  • 30. Cell growth- and P53-dependent transcriptional activity of the midkine promoter confers suicide gene expression in tumor cells.
    Yu L, Ugai S, O-Wang J, Namba M, Kadomatsu K, Muramatsu T, Matsubara S, Sakiyama S, Tagawa M.
    Oncol Rep; 2003 Feb 02; 10(5):1301-5. PubMed ID: 12883697
    [Abstract] [Full Text] [Related]

  • 31. p53 is a NF-Y- and p21-independent, Sp1-dependent repressor of cyclin B1 transcription.
    Innocente SA, Lee JM.
    FEBS Lett; 2005 Feb 14; 579(5):1001-7. PubMed ID: 15710382
    [Abstract] [Full Text] [Related]

  • 32. Efficient translocation and apoptosis induction by adenovirus encoded VP22-p53 fusion protein in human tumor cells in vitro.
    Roy I, Holle L, Song W, Holle E, Wagner T, Yu X.
    Anticancer Res; 2002 Feb 14; 22(6A):3185-9. PubMed ID: 12530063
    [Abstract] [Full Text] [Related]

  • 33. LMO3 interacts with p53 and inhibits its transcriptional activity.
    Larsen S, Yokochi T, Isogai E, Nakamura Y, Ozaki T, Nakagawara A.
    Biochem Biophys Res Commun; 2010 Feb 12; 392(3):252-7. PubMed ID: 19995558
    [Abstract] [Full Text] [Related]

  • 34. Combined transcriptional and transductional targeting improves the specificity and efficacy of adenoviral gene delivery to ovarian carcinoma.
    Barker SD, Dmitriev IP, Nettelbeck DM, Liu B, Rivera AA, Alvarez RD, Curiel DT, Hemminki A.
    Gene Ther; 2003 Jul 12; 10(14):1198-204. PubMed ID: 12833129
    [Abstract] [Full Text] [Related]

  • 35. [Gene therapy targeting for carcinoma regulated by E2F-1 promoter].
    Zhang XW, Meng ZH, Zhao JS, Zhang D, Xie YJ, Gao SH, Wang CY.
    Zhonghua Wai Ke Za Zhi; 2006 Dec 01; 44(23):1636-9. PubMed ID: 17359698
    [Abstract] [Full Text] [Related]

  • 36. Tumor-specific adenovirus-mediated PUMA gene transfer using the survivin promoter enhances radiosensitivity of breast cancer cells in vitro and in vivo.
    Wang R, Wang X, Li B, Lin F, Dong K, Gao P, Zhang HZ.
    Breast Cancer Res Treat; 2009 Sep 01; 117(1):45-54. PubMed ID: 18791823
    [Abstract] [Full Text] [Related]

  • 37. Mutant p53 proteins have diverse intracellular abilities to oligomerize and activate transcription.
    Miller CW, Chumakov A, Said J, Chen DL, Aslo A, Koeffler HP.
    Oncogene; 1993 Jul 01; 8(7):1815-24. PubMed ID: 8510927
    [Abstract] [Full Text] [Related]

  • 38. SV40 T antigen abrogates p53-mediated transcriptional activity.
    Jiang D, Srinivasan A, Lozano G, Robbins PD.
    Oncogene; 1993 Oct 01; 8(10):2805-12. PubMed ID: 8378089
    [Abstract] [Full Text] [Related]

  • 39. Human synapsin 1 gene promoter confers highly neuron-specific long-term transgene expression from an adenoviral vector in the adult rat brain depending on the transduced area.
    Kügler S, Kilic E, Bähr M.
    Gene Ther; 2003 Feb 01; 10(4):337-47. PubMed ID: 12595892
    [Abstract] [Full Text] [Related]

  • 40. New complex Ad vectors incorporating both rtTA and tTS deliver tightly regulated transgene expression both in vitro and in vivo.
    Rubinchik S, Woraratanadharm J, Yu H, Dong JY.
    Gene Ther; 2005 Mar 01; 12(6):504-11. PubMed ID: 15660114
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 17.